Health·3,523 stories
Health News — Page 27
Light-Activated Eye Drops Restore Vision in Blind Mice
Researchers at IBEC have developed light-activated compounds that restored light perception and visually guided behavior in blind mice, with two compounds working when administered as simple eye drops
AstraZeneca-Ionis Heart Drug Fails; Alnylam Watches
AstraZeneca and Ionis detailed the surprise failure of their experimental heart disease drug at a European Society of Cardiology meeting, with Alnylam closely watching the results as a fellow develope
NASA's Roman Space Telescope Launches August 30
NASA's Nancy Grace Roman Space Telescope, a wide-field infrared observatory designed to complement JWST, is set to launch from Cape Canaveral on August 30 to map dark matter and dark energy and direct
Researchers followed 400,000 kids for 20 years and found a lasting pre-K advantage
A 20-year study of 400,000 Miami-Dade students found children who attended public school pre-K outperformed peers through high school, with researchers pointing to teacher training requirements as the
RFK Jr's IACC adopts autism plan critics call 'fringe science'
A federal panel handpicked by RFK Jr adopted a sweeping autism research roadmap that scientists and autism advocates warn diverts funds from proven genetics work toward unproven alternative therapies
AstraZeneca Heart Drug Fails Trial
AstraZeneca's experimental heart disease drug failed a Phase 3 trial, showing no added benefit for patients already on stabilizer therapy, reshaping the competitive landscape for ATTR-CM treatments.
Physicist's new book links space-time study to democracy
Theoretical physicist Chanda Prescod-Weinstein publishes "The Edge of Space-Time," arguing that engaging with fundamental questions about the universe is essential to democracy and warning that scienc
FDA approves first targeted pancreatic cancer drug
The FDA approved Revolution Medicines' advanced pancreatic cancer treatment — the first to attack a genetic cause after trial data nearly doubled median survival over standard chemo — while the Trump
FDA Approves Roivant's Lisraya for Dermatomyositis
The FDA on Thursday approved Roivant's brepocitinib (brand name Lisraya), a once-daily oral pill for dermatomyositis — a rare autoimmune disease affecting an estimated 40,000–70,000 Americans who curr
STAT+: Hospitals plot their response to funding cuts
Hospitals that hoped to lobby Congress for expanded payments and looser regulations are instead diverting their political capital to blocking $1 trillion in health care spending cuts that helped fund
UPFs tied to 30% higher prostate cancer risk
A Florida Atlantic University study of more than 17,000 U.S. men found that higher ultra-processed food consumption was linked to a 24%–31% higher prostate cancer risk after adjusting for age, smoking
Open Dialogue therapy cuts psychiatric admissions by two-thirds
A Lancet Psychiatry study of 500 NHS patients found that Open Dialogue therapy — which involves patients' families and social networks — cut psychiatric hospital admissions to a third of usual rates,
First Live AI-Assisted Brain Surgery Removes Tumor
A patient in the UK became the first to undergo brain surgery with live AI assistance, successfully removing a pituitary tumour while preserving vision and critical brain structures.
FDA Approves Rasonque, First Targeted Pancreatic Cancer Drug
The FDA approved Revolution Medicines' daraxonrasib — sold as Rasonque — as the first targeted therapy for advanced pancreatic cancer, with trial data showing patients lived nearly twice as long as th
Healthcare Built to Prescribe, Can't Help You Quit
Modern medicine excels at prescribing drugs but lacks the clinical infrastructure and evidence base to help patients safely stop taking them — a gap visible in antidepressant discontinuation struggles
Pharma's Lp(a) Bet Faces Key Data
Several large pharmaceutical companies are betting that drugs targeting lipoprotein(a) will be the next big advance in cardiovascular medicine, and key clinical data on this approach is imminent.
What you eat before age 2 may affect your health 70 years later
A study of over 64,000 Britons born around the end of postwar sugar rationing found that those with more sugar exposure in their first 1,000 days had higher rates of several cancers, faster cellular a
Novartis leads Lp(a) drug race as treatments near market
Drugmakers including front-runner Novartis are advancing experimental treatments through late-stage trials targeting Lp(a), a genetically driven cardiovascular risk factor affecting roughly 1 in 5 peo
STAT+: After a years-long slump, Massachusetts biopharma sector has come roaring back in 2026
Massachusetts' biopharma workforce contracted by roughly 3,600 jobs in 2025 — the first decline since at least 2002 — driven by industry headwinds and uncertainty over federal research funding, accord
FDA Preps New Guidance on Generative AI Devices
STAT+ teases coverage of two health-tech developments: a new FDA discussion paper on generative AI medical devices and news from Epic's annual User Group Meeting, with the full reporting behind a payw
Get the Health newsletter
Curated health stories, every morning. Free.
No spam. Unsubscribe anytime.